The invention relates to a novel route to the manufacture of spiroketal products, more specifically to Amber Ketal, through the use of a bioprocess.
Spiroketals are known in the art and are commercially useful as fragrance materials. The industrial processes for the production of these compounds generally start form sclareol and manool and yield mixtures of the oxygenated spiroketals of formula
For example, U.S. Pat. No. 3,144,465 discusses the synthesis of a mixture of the oxygenated spiroketals I and II (R═O) starting from manool, by the epoxidation with peracetic, perbenzonic, monoperphthalic, percamphoric or performic acid, followed by oxidation. A further process also described [E. Demole, Experientia, 20, 609 (1964)] the semi-industrial production of a mixture of the oxygenated spiroketals I and II (R═O) starting from manool, which combines the epoxidation by perbenzoic acid with the ozonolysis of the resulting epoxide, the products thus obtained being then treated with p-toluenesulphonic acid. These methods lead to mixtures of the spiroketals I and II (R═O) in yields not higher than 30% and have the disadvantage of using toxic and/or expensive reagents, as well as the added disadvantage of producing mixtures of compounds in which one of the components is odorless, thereby reducing the commercial value of the final product for the application in the industry of perfumery.
As discussed in U.S. Pat. Nos. 4,970,163 and 5,212,078; U.S. Pat. No. 4,798,799 discloses the utilization of a culture containing the microorganism Hyphozyma roseoniger ATCC 20624 capable of producing the diol having the structure:
in a recoverable quantity upon the transformation of compounds including the sclareol compound having the structure:
Table 4, Col. 12 of this patent discloses yields of 96% when carrying out the reaction:
under fermentation conditions using ATCC 20624.
U.S. Pat. Nos. 4,970,163 and 5,212,078 disclose carrying out the reaction
via microbiological methods using the organism Bensingtonia ciliata, ATCC 20919 and carrying out the reaction
via microbiological methods using the organism Cryptococcus laurentii, ATCC 20920.
Since manool, manool ketone and larixol ketone are valuable intermediates in production of the important compounds in perfumery, such as amber ketal, there is an ongoing need for the methods of carrying out these reactions to be developed.
One embodiment of the invention provides a method for preparing manool from larixol via the microbiological process using yeast. In a particularly preferred embodiment the yeast is the organism Bensingtonia ciliata, ATCC 20919.
Another embodiment of the invention provides a method for preparing manool ketone from manool via the microbiological process using yeast. In a particularly preferred embodiment the yeast is the organism Cryptococcus laurentii, ATCC 20920.
The invention also provides a method for preparing manool ketone from larixol via the microbiological process using yeast, with the preferred embodiment being the organisms Bensingtonia ciliata, ATCC 20919 and Cryptococcus laurentii, ATCC 20920.
These and other embodiments of the present invention will be apparent by reading the following specification and claims.
As was described in the Background of the Invention, the present invention is directed to the discovery that yeast can be used to produce the fragrance materials set forth in this application. Yeasts have been previously employed to manufacture diol and lactone compounds. There was no suggestion that these yeasts could be used to produce the spiroketals of the present invention.
More, specifically, there is no teaching or suggestion in the prior art of either carrying out the reaction of
via microbiological methods using a yeast such as the organism Bensingtonia ciliata, ATCC 20919
or carrying out the reaction
via microbiological methods using yeast such as the organism Cryptococcus laurentii, ATCC 20920.
or carrying out the reaction
via microbiological methods using yeast such as the organism Cryptococcus laurentii, ATCC 20920.
The yeasts of the present invention are available from the American Type Culture Collection (ATCC) from Manassas, Va. USA. The yeasts are commercially available from ATCC by use of its webpage, atcc.org. Both yeasts, Bensingtonia ciliate and Cryptococcus laurenti are previously on deposit with ATCC from earlier work performed by the assignee of the present application, International Flavors & Fragrances Inc., New York, N.Y. 10019.
The yeasts of the present invention can be incorporated in any appropriate media such as agar, with the accompanying nutrients such as sugars and lipids, growth factors and the like. In the following examples media was prepared using NH4NO3, KH2PO4, MgSO4.7H2O and yeast extract. As noted in the following examples, Pluronic L92, available from BASF for the purpose of dispersed substrates. Obviously the key factor is that the components are compatible with yeasts and do not negatively impact the yeasts.
The starting materials of the present invention, larixol and manool are commercially available fragrance materials and are available from International Flavors & Fragrances Inc.
The present invention is conducted by contacting the yeasts with the starting materials for a period of from about 72 hours to about 240 hours, preferably from about 110 hours to about 200 hours and most preferably from about 144 hours to about 168 hours. The temperature that the yeasts is provided ranges from about 12° C. to about 33° C., more preferably at about 25° C. Preferably, the yeasts and the starting materials are contacted by mild agitation.
The present invention provide the desired products in yields, Manool from Larixol is greater than 15%, preferably greater then 25%, most preferably greater then 40% by weight. The desired yield of Manool ketone from Manool is greater than 87%, preferably greater then 90%, most preferably greater then 92% by weight. The desired yield of Larixol ketone from Larixol is greater than 72%, preferably greater then 80%, most preferably greater then 85% by weight. After the products are obtained the desired products are separated from the other reactant materials by conventional processes such as filtration, distillation and other techniques known in the art.
The following examples are provided as specific embodiments of the present invention. Other modifications of this invention will be readily apparent to those skilled in the art, without departing from the scope of this invention. As used herein all percentages are weight percent unless noted to the contrary.
Conversion of Larixol Using Bensingtonia ciliata ATCC 20919, Cryptococcus laurentii ATCC 20920, Cryptococcus albidus saito, skinner var. albidus ATCC 20918, Cryptococcus albidus ATCC 20921.
The following medium was prepared:
4 Flasks were prepared. Each 500 ml flask contained 100 ml medium and 1 gram of Manool (98%) in Pluronic L92® (2:1).
Each flask was inoculated with 5 ml of a 48 hour grown cell culture in dextrose at 25° C., and 150 revolutions per minute (rpm). Product and substrate was monitored by gas chromatography (GC) against known standards.
In the following table the following codes are used:
S: Substrate
P: Product
I: Intermediate
TI: Trace Intermediate.
The “substrate” is Larixol having the structure:
The “product” is Manool having the structure:
The “intermediate” is Larixol ketone having the structure:
The “trace intermediate” is Manool ketone having the structure:
Bensingtonia ciliata
Cryptococcus laurentii
Cryptococcus albidus
Cryptococcus albidus
Preparation of Manool from Larixol using Bensingtonia ciliata ATCC 20919 Reactions:
The following medium was prepared:
Into a 500 ml flask was placed 100 ml medium and a 1:1 mixture of Larixol powder: Pluronic L92®. 1 gram of the Manool and 1 gram of Pluronic L92® mixture was added to the flask and inoculated with 5 ml of isolate of Bensingtonia ciliata ATCC 20919. After one week at 25° C. and 150 rpm, the resulting product was extracted with 300 ml volumes of ethyl acetate and then dried over anhydrous sodium sulfate. The solvent was removed on a rotary evaporator. The residue was dissolved in ethyl acetate. The resulting extract permitted to evaporate for a period of 24 hours where upon crystal (150 mg) of Manool was recovered.
Conversion of Manool Using Bensingtonia ciliata ATCC 20919, Cryptococcus laurentii ATCC 20920, Cryptococcus albidus saito, skinner var. albidus ATCC 20918, Cryptococcus albidus ATCC 20921.
The following medium was prepared:
Four flasks were prepared. Each 500 ml flask contained 100 ml medium and 1 gram of Manool (98%) in Pluronic L92® (2:1).
Each flask was inoculated with 5 ml of a 48 hour grown cell culture in dextrose at 25° C., and 150 revolutions per minute (rpm). Product and substrate was monitored by gas chromatography (GC) against known standards.
In the following table the following codes are used:
S: Substrate
P: Product
I: Intermediate
TI: Trace Intermediate.
The “substrate” is Manool having the structure:
The “product” is Manool Ketone having the structure:
The “intermediate” is Manool Alcohol having the structure:
The “trace intermediate” is Manool Aldehyde having the structure:
Cryptococcus laurentii
Bensingtonia ciliata
Cryptococcus albidus
Cryptococcus albidus
Preparation of Manool Ketone from Manool using Cryptococcus laurentii ATCC 20920 Reactions:
The following medium was prepared:
Into a 500 ml flask was placed 100 ml medium and a 1:1 mixture of Manool powder: Pluronic L92®. 1 Gram of the Manool and 1 gram of Pluronic L92® mixture was added to the flask and inoculated with 5 ml of isolate of Cryptococcus laurentii ATCC 20920. After one week at 25° C. and 150 rpm, the resulting product was extracted with 300 ml volumes of ethyl acetate and then dried over anhydrous sodium sulfate. The solvent was removed on a rotary evaporator. The residue was dissolved in ethyl acetate. The resulting extract is permitted to evaporate for a period of 24 hours where upon liquid (approximately 350 mg) of Manool Ketone was recovered.
Preparation of Manool Ketone from Manool using Cryptococcus laurentii ATCC 20920
Reactions:
In each of the following examples, mixtures of Manool and Pluronic L92® were prepared to form a Manool paste and added with 50% glucose. A fermentation broth was prepared containing the indicated amounts of:
NH4NO3
KH2PO4
MgSO4.7H2O
Yeast Extract
Antifoam Material (“AF”)
Water.
The Manool emulsion and 50% glucose solution was added to the fermentation shake flask containing the fermentation medium and the cultures, Cryptococcus laurentii ATCC 20920. At the end of the given period of time liquid Manool Ketone was recovered.
Inoculation:
1 Fresh shake flask (500 ml/48 hr)
Add 315 g emulsion of Manool
315 of emulsion were added over the course of the fermentation up to a total of 420 g emulsion or 120 g Manool (12 g/L).
Recovery: 10.5 g/L Manool Ketone in 7 days.
NMR of Manool Ketone
NMR. Both 1H and 13C NMR experiments were performed on a Bruker Avance 500-MHz spectrometer. CDCl3 containing TMS was used as solvent.
Manool Ketone: 1H NMR (CDCl3, 500 MHz) δ 0.69 (s, 3H), 0.80 (s, 3H), 0.87 (s, 3H), 1.07-1.10 (m, 2H), 1.18-1.21 (m, 1H), 1.31-1.40 (m, 2H), 1.50-1.58 (m, 4H), 1.71-1.73 (m, 1H), 1.78-1.86 (m, 2H), 1.95-1.98 (m, 1H), 2.09 (s, 3H), 2.30-2.38 (m, 2H), 2.56-259 (m, 1H), 4.44 (s, 1H), 4.82 (s, 1H); 13C NMR (CDCl3, 500 MHz) δ 14.1 (CH3), 17.3 (CH2), 19.2 (CH2), 21.5 (CH3), 24.3 (CH2), 29.8 (CH3), 33.36 (C), 33.44 (CH3), 38.1 (CH2), 38.8 (CH2), 39.6 (C), 42. 0, (CH2), 42.7 (CH2), 55.3 (CH), 56.1 (CH), 106.2 (CH2), 148.0 (C), 208.9 (C).
Manool: 1H NMR (CDCl3, 500 MHz) δ 0.67 (s, 3H), 0.80 (s, 3H), 0.87 (s, 3H), 1.02 (d, J=13.0 Hz, oft, J=3.9 Hz, 1H), 1.07 (d, J=12.6 Hz, of d, J=2.7 Hz, 1H), 1.17 (d, J=13.4 Hz, of t, J=4.0 Hz, 1H), 1.27 (s, 3H), 1.29-1.40 (m, 4H), 1.44-1.49 (m, 1H), 1.50-1.61 (m, 4H), 1.67-1.74 (m, 2H), 1.76-1.79 (m, 1H), 1.96 (d, J=12.9 Hz, oft, J=5.0 Hz, 1H), 2.35-2.39 (m, 1H), 4.48 (s, 1H), 4.80 (s, 1H), 5.05 (d, J=10.8 Hz, of d, J=1.2 Hz, 1H), 5.20 (d, J=17.4 Hz, of d, J=1.19 Hz, 1H), 5.91 (d, J=17.3 Hz, of d, J=10.8 Hz, 1H); 13C NMR (CDCl3, 500 MHz) δ 14.4 (CH3), 17.6 (CH2), 19.4 (CH2), 21.7 (CH3), 24.4 (CH2), 28.0 (CH3), 33.55 (C), 33.6 (CH3), 38.4 (CH2), 39.1 (CH2), 39.8 (C), 41.4 (CH2), 42.2 (CH2), 55.6 (CH), 57.2 (CH), 73.6 (C), 106.3 (CH2), 111.6 (CH2), 145.1 (CH), 148.7 (C).
Preparation of Larixol Ketone from Larixol using Cryptococcus laurentii ATCC 20920
Reactions:
The following medium was prepared:
Into a 500 ml flask was placed 100 ml medium and a 1:1 mixture of Larixol powder: Pluronic L92®. 1 Gram of the Larixol and 1 gram of Pluronic L92® mixture was added to the flask and inoculated with 5 ml of isolate of Cryptococcus laurentii ATCC 20920. After one week at 25° C. and 150 rpm, the resulting product was extracted with 300 ml volumes of ethyl acetate and then dried over anhydrous sodium sulfate. The solvent was removed on a rotary evaporator. The residue was dissolved in ethyl acetate. The resulting extract is permitted to evaporate for a period of 24 hours where upon pure crystals (550 mg) of Larixol ketone.
were recovered.
Preparation of Larixol Ketone from Larixol using Cryptococcus laurentii ATCC 20920
Reactions:
Inoculation:
1 Fresh shake flask (500 ml/48 hr)
Add 273 g emulsion of Larixol
273 g of emulsion was added over the course of the fermentation up to a total of 364 g emulsion or 120 g Larixol (12 g/L).
Product Recovery:
Products were recovered by sieving, dissolving in Ethyl acetate and recrystallizing with heating and cooling.
Final Recovery: 8.6 g/L Manool Ketone in 7 days.
NMR of Larixol Ketone
1H NMR (CDCl3, 500 MHz) δ 0.71 (s, 3H), 1.01 (s, 3H), 1.07-1.15 (m, 3H), 1.16 (s, 3H), 1.35-1.39 (m, 1H), 1.45-1.57 (m, 3H), 1.59-1.61 (m, 1H), 1.74-1.77 (m, 1H), 1.85-1.91 (m, 1H), 2.00-2.05 (t, J=11.4 Hz, 1H), 2.11 (s, 3H), 2.30-2.37 (m, 1H), 2.56-2.62 (m, 1H), 2.6 (d, J=12.2 Hz, of d, J=4.87 Hz, 1H), 3.38-3.67 (m, 1H), 3.83 (d, J=10.7 Hz, of t, J=4.9 Hz, 1H), 4.51 (d, J=1.3 Hz, 1H), 4.90 (d, J=1.3 Hz, 1H); 13C NMR (CDCl3, 500 MHz) δ 15.9 (CH3), 17.7 (CH2), 19.1 (CH2), 22.3 (CH3), 30.0 (CH3), 33.9 (C), 36.6 (CH3), 39.2 (CH2), 39.4 (C), 42.8 (CH2), 43.7 (CH2), 49.0 (CH2), 55.4 (CH), 60.4 (CH), 71.6 (CH), 108.2 (CH2), 145.3 (C), 209.1(C).
NMR of Larixol
1H NMR (CDCl3, 500 MHz) δ 0.69 (s, 3H), 1.01 (s, 3H), 1.02-1.04 (m, 1H), 1.10 (d, J=10.6 Hz, 1H), 1.17 (s, 3H), 1.20-1.32 (m, 3H), 1.27 (s, 3H), 1.34-1.38 (m, 2H), 1.45-1.50 (m, 2H), 1.53-1.58 (m, 3H), 1.71-1.76 (m, 2H), 2.04 (t, J=11.2 Hz, 1H), 2.67 (d, J=12.1 Hz, of d, J=4.8 Hz, 1H), 3.83 (m, 1H), 4.60 (s, 1H), 4.89 (s, 1H), 5.05 (d, J=10.8 Hz, 1H), 5.20 (d, J=17.4 Hz, 1H), 5.91 (d, J=17.3 Hz, of d, J=10.8 Hz, 1H); 13C NMR (CDCl3, 500 MHz) δ 16.0 (CH3), 18.0 (CH2), 19.1 (CH2), 22.3 (CH3), 27.7 (CH3), 33.9 (C), 36.6 (CH3), 39.3 (CH2), 39.6 (C), 41.4 (CH2), 43.7 (CH2), 49.2 (CH2), 56.5 (CH), 60.5 (CH), 71.6 (CH), 73.5 (C), 108.4 (CH2), 111.6 (CH2), 145.2 (CH), 145.6 (C).
Number | Name | Date | Kind |
---|---|---|---|
3144465 | Ruzicka et al. | Aug 1964 | A |
4798799 | Farbood et al. | Jan 1989 | A |
4970163 | Farbood et al. | Nov 1990 | A |
5212078 | Farbood et al. | May 1993 | A |
5440050 | do Ceu Goncalves da Costa et al. | Aug 1995 | A |
Number | Date | Country | |
---|---|---|---|
20060154347 A1 | Jul 2006 | US |